Loss of heterozygosity and lack of mutations of the XPG/ERCC5 DNA repair gene at 13q33 in prostate cancer.
about
Cis-acting genetic variation at an E2F1/YY1 response site and putative p53 site is associated with altered allele-specific expression of ERCC5 (XPG) transcript in normal human bronchial epithelium.The human XPG gene: gene architecture, alternative splicing and single nucleotide polymorphisms.Pattern of sequence variation across 213 environmental response genes.Polymorphisms in 2 and 5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review
P2860
Loss of heterozygosity and lack of mutations of the XPG/ERCC5 DNA repair gene at 13q33 in prostate cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Loss of heterozygosity and lac ...... e at 13q33 in prostate cancer.
@ast
Loss of heterozygosity and lac ...... e at 13q33 in prostate cancer.
@en
type
label
Loss of heterozygosity and lac ...... e at 13q33 in prostate cancer.
@ast
Loss of heterozygosity and lac ...... e at 13q33 in prostate cancer.
@en
prefLabel
Loss of heterozygosity and lac ...... e at 13q33 in prostate cancer.
@ast
Loss of heterozygosity and lac ...... e at 13q33 in prostate cancer.
@en
P2093
P2860
P1433
P1476
Loss of heterozygosity and lac ...... ne at 13q33 in prostate cancer
@en
P2093
A Degeorges
E R Hyytinen
H F Frierson
P2860
P304
P356
10.1002/(SICI)1097-0045(19991101)41:3<190::AID-PROS6>3.0.CO;2-2
P577
1999-11-01T00:00:00Z